BioCardia, Inc. (BCDA) vs Dare Bioscience, Inc. (DARE)
- BioCardia, Inc. BCDA 0.92 −2.13%
- Dare Bioscience, Inc. DARE 0.72 −2.70%
BioCardia, Inc. and Dare Bioscience, Inc. are both Biotechnology companies. BioCardia, Inc. and Dare Bioscience, Inc. are of similar size ($14.6M and $14.2M). Dare Bioscience, Inc. grew revenue faster over the last twelve months: 7,817.5% against 0.71%. BioCardia, Inc. has the higher net margin (0.00% vs −804.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, BioCardia, Inc. leads on 9 and Dare Bioscience, Inc. on 6.
Valuation
Profitability
| Metric | BCDA | DARE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 58.84% | 65.16% |
| Operating margin | 0.00% | (813.35%) | 0.00% |
| Net margin | 0.00% | (804.33%) | 0.00% |
| Free cash flow margin | 0.00% | (849.36%) | 0.00% |
| Return on equity | (1,803.19%) | 165.29% | (56.36%) |
| Return on assets | (214.47%) | (62.16%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack